文献速递皮肤感染湿疹皮炎与荨麻疹

从病毒感染到皮肤病变:COVID-19及新冠后状态皮肤表现机制解读

From Viral Infection to Skin Affliction: Unveiling Mechanisms of Cutaneous Manifestations in COVID-19 and Post-COVID Conditions.
PubMed 文献 · J Invest Dermatol · 2024-12-10

综述梳理COVID-19皮肤表现的临床与病理生理特征,指出麻疹样、丘疱疹样及青斑样/紫癜样皮疹与病毒诱导的内皮细胞损伤相关并见于中重度疾病,而假性冻疮与受保护个体中浆细胞样树突状细胞过度产生IFN-1相关,并探讨新冠后状态与皮肤病持续存在的关联。

要点

  • 麻疹样、丘疱疹样及青斑样/紫癜样皮疹与病毒诱导内皮损伤相关,见于中重度COVID-19。
  • 假性冻疮(COVID脚趾)与受保护个体中pDC过度产生IFN-1相关。
  • 需关注新冠后状态(长新冠)中COVID-19相关皮肤病的持续存在。

核心结论

  • COVID-19皮肤表现机制涉及病毒直接细胞病变效应与失调的IFN-1应答两条通路。
  • 不同皮疹类型对应不同机制与疾病严重程度。
  • 新冠后状态可能参与COVID-19相关皮肤病的持续。

研究设计与样本

  • 综述类文章,检索范围原文未报告。

主要发现

  • 麻疹样、丘疱疹样及青斑样/紫癜样皮疹与病毒诱导的内皮细胞损伤相关,并 linked to 中重度疾病。
  • 假性冻疮与受保护个体中浆细胞样树突状细胞过度产生IFN-1相关。

临床怎么用

  • 依据皮疹类型辅助判断COVID-19疾病严重程度与免疫状态。
  • 对长新冠患者持续皮肤病变保持关注与随访。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

COVID-19 skin manifestations are multifaceted, ranging from urticaria, morbilliform or papulovesicular rash, livedoid purpuric lesions, and to pseudochilblains (also called COVID toes). Recent insights into the mechanism of these manifestations have highlighted that morbilliform, papulovesicular, and livedoid/purpuric rashes are related to virus-induced endothelial cell damage and linked to moderate-to-severe disease, whereas pseudochilblains are related to an exaggerated IFN-1 production by plasmacytoid dendritic cells in protected individuals. In this paper, we will review the clinical and physiopathological features of cutaneous COVID-19 manifestations in relation to the direct viral cytopathic effects and dysregulated IFN-1 responses. We will also review the emerging insights into post-COVID conditions (also termed long COVID) and how they may be implicated in the persistence of COVID-19-associated skin diseases.

来源:J Invest Dermatol,查看原文。版权归原作者所有。

引用

  1. Brahimi N, Croitoru D, Saidoune F, et al. From Viral Infection to Skin Affliction: Unveiling Mechanisms of Cutaneous Manifestations in COVID-19 and Post-COVID Conditions. J Invest Dermatol. 2024. PMID: 39665720. doi:10.1016/j.jid.2024.03.047

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。